Dow Up 0.07% Nasdaq Up 0.61%

Coherus Biosciences, Inc. (CHRS)

-NasdaqGM
13.59 Down 0.16(1.16%) Nov 26, 4:00PM EST
Prev Close:13.75
Open:13.77
Bid:N/A
Ask:13.95 x 300
1y Target Est:7.35
Beta:1.71
Next Earnings Date:N/A
Day's Range:13.25 - 14.12
52wk Range:12.70 - 14.49
Volume:55,353
Avg Vol (3m):95,760
Market Cap:435.57M
P/E (ttm):N/A
EPS (ttm):-2.65
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):42.79
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jan-13) :N/A
Quarterly EPS Est (Jul-12) :N/A
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Coherus Biosciences, Inc., a late-stage clinical biologics platform company, focuses on developing and commercializing biosimilar products worldwide. Its clinical stage pipeline consists of CHS-0214, an etanercept biosimilar candidate, which is in... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback